Cargando…
From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation—Hemodynamics and Behavior
Autores principales: | Zamolodchikova, Tatyana S., Tolpygo, Svetlana M., Kotov, Alexander V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595096/ https://www.ncbi.nlm.nih.gov/pubmed/34803713 http://dx.doi.org/10.3389/fphar.2021.772217 |
Ejemplares similares
-
Cathepsin G—Not Only Inflammation: The Immune Protease Can Regulate Normal Physiological Processes
por: Zamolodchikova, Tatyana S., et al.
Publicado: (2020) -
Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022) -
Differential Toxicity of mDia Formin-Directed Functional Agonists and Antagonists in Developing Zebrafish
por: LeCorgne, Hunter, et al.
Publicado: (2018) -
Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
por: Altieri, Danielle I., et al.
Publicado: (2023) -
Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
por: Leal, Marcos André Soares, et al.
Publicado: (2020)